Brookline initiated coverage of OS Therapies with a Buy rating and $9 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSTX:
Education
About Us
Working with TipRanks
Follow Us
